# Characterization of the Melanoma-Specific Immune Response

> **NCT00368615** · — · UNKNOWN · sponsor: **University of California, Davis** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00368615
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368615, "Characterization of the Melanoma-Specific Immune Response". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00368615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*